Tenon Medical, Inc.
TNON
$0.76
$0.00-0.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 92.34% | 32.24% | -37.40% | 0.97% | -4.70% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 92.34% | 32.24% | -37.40% | 0.97% | -4.70% |
| Cost of Revenue | 11.27% | -14.71% | -25.99% | 61.85% | 67.47% |
| Gross Profit | 188.10% | 84.93% | -47.87% | -31.28% | -36.85% |
| SG&A Expenses | 13.49% | -0.60% | -28.48% | 0.06% | -1.73% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 10.25% | -7.70% | -28.33% | 4.21% | -0.15% |
| Operating Income | 9.68% | 18.72% | 26.21% | -4.88% | -1.02% |
| Income Before Tax | 8.26% | -4.87% | 27.63% | -1.12% | 1.50% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 8.26% | -4.87% | 27.63% | -1.12% | 1.50% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 8.26% | -4.87% | 27.63% | -1.12% | 1.50% |
| EBIT | 9.68% | 18.72% | 26.21% | -4.88% | -1.02% |
| EBITDA | 9.16% | 18.54% | 25.75% | -6.72% | -0.26% |
| EPS Basic | 70.50% | 88.85% | 95.53% | 89.96% | 90.08% |
| Normalized Basic EPS | 70.51% | 91.45% | 95.53% | 89.96% | 90.08% |
| EPS Diluted | 70.50% | 88.85% | 95.53% | 89.96% | 90.08% |
| Normalized Diluted EPS | 70.51% | 91.45% | 95.53% | 89.96% | 90.08% |
| Average Basic Shares Outstanding | 210.99% | 840.71% | 1,518.55% | 907.56% | 893.38% |
| Average Diluted Shares Outstanding | 210.99% | 840.71% | 1,518.55% | 907.56% | 893.38% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |